Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

Published Date: 13 Sep 2024

Two-trial analysis shows about a 40% decreased risk of disease recurrence or death

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

2.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

3.

Pollution exposure may affect lung cancer in women who have never smoked

4.

Germline Variants Predict Lobular Breast Cancer Recurrence

5.

The biology of cancer as well as potential treatment options are examined by experts.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot